UCSF Benioff Child Hosp Oakland-Hemoglobinopathies Testing

The Michigan Department of Health and Human Services, Bureau of Laboratories is issuing a Notice of Intent to Negotiate and Contract with a Single Provider for hemoglobinopathies confirmatory testing services on dried blood spots as part of newborn screening, with a dispute-response deadline of October 28, 2026 at 1:59 PM EST. This is a sole-source procurement; bidders who dispute exclusive availability must submit written objections by the deadline through SIGMA describing any equivalent products or services.

The scope encompasses confirmatory testing for seven common alpha-globin deletions, Constant Spring analysis, alpha multiplex ligation-dependent probe amplification (MLPA), beta sequencing, beta MLPA, and hereditary persistence of fetal hemoglobin (HPFH) analysis, along with interpretation of results. Work is performed at the intended provider's location in Oakland, California.

The contract is structured as a new agreement with a minimum three-year term and five one-year renewal options. Children's Hospital Oakland Research Institute (CHORI), located at 5700 Martin Luther King Jr. Way, Oakland, California 94609 (Vendor ID CV0066424), has been identified as the intended sole source based on its unique capability to conduct these specialized tests on dried blood spots and provide appropriate clinical interpretation. No contract value or budget details are disclosed in this notice of intent.

Questions must be submitted via email to Wanda Rademacher, the solicitation manager, no later than October 23, 2026 at 3:00 PM EST, with answers posted on www.michigan.gov/SIGMAVSS. The procurement is classified under NIGP commodity code 94855 for Medical and Laboratory Services (Non-Physician).